하늘바이오농업회사법인

비상장계속사업자

skybio

윤효미

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

하늘바이오농업회사법인

Business Reg. No. 6118116825 · CEO 윤효미

I.Investment Overview

Target하늘바이오농업회사법인 (6118116825)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명하늘바이오농업회사법인
영문명skybio
대표자윤효미
사업자등록번호6118116825
법인등록번호1914110007485
설립일2009.01.01
종업원수32명

V.Workforce

32

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW102.92021116.92022132.1202319320242882025
영업이익100M KRW3.8202110.9202212.6202324.72024332025
순이익100M KRW1.620216.920227.6202313.4202421.62025
Item20252024202320222021
자산총계307.4억원171.7억원151.2억원135억원116.9억원
부채총계208.9억원118.3억원109.7억원101.2억원89.9억원
자본총계98.5억원53.3억원41.5억원33.9억원27억원
매출액288억원193억원132.1억원116.9억원102.9억원
영업이익33억원24.7억원12.6억원10.9억원3.8억원
순이익21.6억원13.4억원7.6억원6.9억원1.6억원

VII.Financial Ratios

FY2025 basis

11.45%

영업이익률

7.5%

순이익률

7.02%

ROA

21.92%

ROE

212.02%

부채비율

32.05%

자기자본비율

VIII.R&D Activity

Fields 농림수산식품 > 식품과학

Keywords 자동화, 품질, 세계화

YearProjectsPapersPatents
2018100
2017100

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

하늘바이오농업회사법인 투심보고서 | Alpha Lenz